UBS Initiates Coverage On Nuvalent with Neutral Rating, Announces Price Target of $100
Portfolio Pulse from Benzinga Newsdesk
UBS analyst David Dai has initiated coverage on Nuvalent (NASDAQ:NUVL) with a Neutral rating and set a price target of $100.
October 24, 2024 | 11:55 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS has initiated coverage on Nuvalent with a Neutral rating and a price target of $100, indicating a balanced view on the stock's potential.
The Neutral rating suggests that UBS sees no immediate catalyst for significant price movement in either direction. The $100 price target provides a benchmark for investors, but the neutral stance indicates a wait-and-see approach.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100